BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26045308)

  • 21. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
    Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
    J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.
    Kim SJ; Lee JS; Im KC; Kim SY; Park SA; Lee SJ; Oh SJ; Lee DS; Moon DH
    J Nucl Med; 2008 Dec; 49(12):2057-66. PubMed ID: 18997037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
    Michelhaugh SK; Muzik O; Guastella AR; Klinger NV; Polin LA; Cai H; Xin Y; Mangner TJ; Zhang S; Juhász C; Mittal S
    J Nucl Med; 2017 Feb; 58(2):208-213. PubMed ID: 27765857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of [(18)F]-CP18 as a PET imaging tracer for apoptosis.
    Su H; Chen G; Gangadharmath U; Gomez LF; Liang Q; Mu F; Mocharla VP; Szardenings AK; Walsh JC; Xia CF; Yu C; Kolb HC
    Mol Imaging Biol; 2013 Dec; 15(6):739-47. PubMed ID: 23681757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors.
    Xia CF; Chen G; Gangadharmath U; Gomez LF; Liang Q; Mu F; Mocharla VP; Su H; Szardenings AK; Walsh JC; Zhao T; Kolb HC
    Mol Imaging Biol; 2013 Dec; 15(6):748-57. PubMed ID: 23689985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.
    Chen DL; Engle JT; Griffin EA; Miller JP; Chu W; Zhou D; Mach RH
    Mol Imaging Biol; 2015 Jun; 17(3):384-93. PubMed ID: 25344147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
    Webster JM; Morton CA; Johnson BF; Yang H; Rishel MJ; Lee BD; Miao Q; Pabba C; Yapp DT; Schaffer P
    J Nucl Med; 2014 Apr; 55(4):657-64. PubMed ID: 24578242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
    Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
    Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5.
    Rossin R; Kohno T; Hagooly A; Sharp T; Gliniak B; Arroll T; Chen Q; Hewig A; Kaplan-Lefko P; Friberg G; Radinsky R; Evelhoch JL; Welch MJ; Hwang DR
    J Nucl Med; 2011 Jun; 52(6):942-9. PubMed ID: 21571804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy.
    Elvas F; Vanden Berghe T; Adriaenssens Y; Vandenabeele P; Augustyns K; Staelens S; Stroobants S; Van der Veken P; Wyffels L
    Org Biomol Chem; 2019 May; 17(19):4801-4824. PubMed ID: 31033991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
    Hentschel M; Rottenburger C; Boedeker CC; Neumann HP; Brink I
    Clin Nucl Med; 2012 Feb; 37(2):e24-9. PubMed ID: 22228360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
    Tehrani OS; Muzik O; Heilbrun LK; Douglas KA; Lawhorn-Crews JM; Sun H; Mangner TJ; Shields AF
    J Nucl Med; 2007 Sep; 48(9):1436-41. PubMed ID: 17785728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
    Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI
    J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stratification of 18F-labeled PET imaging agents for the assessment of antiangiogenic therapy responses in tumors.
    Goggi JL; Bejot R; Moonshi SS; Bhakoo KK
    J Nucl Med; 2013 Sep; 54(9):1630-6. PubMed ID: 23907757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD.
    Pichler BJ; Kneilling M; Haubner R; Braumüller H; Schwaiger M; Röcken M; Weber WA
    J Nucl Med; 2005 Jan; 46(1):184-9. PubMed ID: 15632051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
    Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
    J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.